NUZ 2.56% 19.0¢ neurizon therapeutics limited

Ann: Positive Interim Study Results from OLE Study in ALS, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,756 Posts.
    lightbulb Created with Sketch. 1499
    Interesting update seems to be working still.

    - Some appear to be showing an increase in function. I wonder what the take is on this or is it just 'noise' in the somewhat subjective measurement.

    - P rating of pro-act vs traditional placebo group. While the P rating is statistically significant when comparing to pro-act, I wonder what fudge factor is built in to account for it not quite the same as placebo. I feel there is a gremlin hiding in this somewhere but perhaps it's just my sceptical curiosity. Does taking it to the most conservative numbers, somewhat account for this in the best way possible (because we will never know how placebo will actually work until the trial).




 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
-0.005(2.56%)
Mkt cap ! $92.46M
Open High Low Value Volume
19.5¢ 20.0¢ 19.0¢ $87.64K 458.2K

Buyers (Bids)

No. Vol. Price($)
4 78140 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 79925 3
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.